Flagship Initiative in Immune System Research and Drug Development Receives €5.6M in Funding
The InFLAMES initiative has received €5.6M funding for 2020–2023 from the Flagship Programme of the Academy of Finland. The Flagship aims at identifying new targets for drug development together with biotechnology and pharmaceutical companies. InFLAMES also develops diagnostics so that targeted therapies could be designed for individual patients.
The research and development cluster is led by Professor and Academician Sirpa Jalkanen from the University of Turku, who is an esteemed and award-winning researcher in immunology and an expert in business collaboration in the medical field. The InFLAMES Flagship is a joint effort of University of Turku and Åbo Akademi University, which have collaborated in drug development and diagnostics research profile for several years. Of the funding, the share of the University of Turku is €4.7M and Åbo Akademi University’s €950,000. The Academy is also prepared to fund the Flagships with an additional 20 million euros over the coming years. InFLAMES is the second flagship initiative of the University of Turku.